Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

Hims, Novo Nordisk and Hers

Digest more
Top News
Overview
 · 1d · on MSN
Hims & Hers stock skyrockets 40% as Novo Nordisk ends feud, agrees to sell Ozempic and Wegovy on platform
Hims & Hers shares jumped more than 50% in premarket trade on Monday after ending a dispute with Novo Nordisk by striking a partnership with the Danish drug giant.

Continue reading

 · 1d · on MSN
Hims & Hers stock soars. Its weight-loss drug battle with Novo Nordisk takes a surprising twist
 · 1d · on MSN
Hims & Hers Health Shares Skyrocket on Novo Nordisk Deal, but Is the Stock Still a Buy?
 · 1d
Hims shares jump on deal to offer Novo's Wegovy, Ozempic on its platform
Hims & Hers' (HIMS.N) shares were up over 50% in premarket trading on Monday following reports Novo Nordisk (NOVOb.CO) plans to sell ​its weight-loss drugs on the telehealth firm's platform, signaling...

Continue reading

 · 1d
Hims & Hers stock surges as Novo Nordisk says it will distribute weight-loss drugs on platform
 · 1d
Novo Nordisk Hims And Hers Deal Reframes Obesity Drug Growth Story
Las Vegas Sun
1h

Hims & Hers Names Kathryn Beiser as Chief Communications Officer

Hims & Hers Health, Inc. (NYSE: HIMS), the leading global health and wellness platform, today announced the appointment of Kathryn Beiser as Chief Communications Officer. In this role, Beiser will lead external and internal communications for the company as it enters a new phase of domestic and international growth.
6h

Asset Manager Exits Shares of Hims & Hers Health

On February 17, 2026, BLKBRD Asset Management, LP, disclosed it sold out its entire stake in Hims & Hers Health (HIMS +5.89%), an estimated $18.07 million trade based on quarterly
1d

What’s Happening With HIMS Stock?

The crucial question is whether the terms of the partnership allow for profitable expansion or merely position HIMS as a low-margin distributor.
  • Privacy
  • Terms